Shigeo Tokumaru

Lymphocyte-to-Monocyte Ratio Is a Predictive Biomarker of Response to Treatment with Nivolumab for Gastric Cancer

Shigeo Tokumaru, Tomonobu Koizumi, Yasushi Sekino et al. · Oncology · 2021 · 25 citations

MEK inhibitor and anti-EGFR antibody overcome sotorasib resistance signals and enhance its antitumor effect in colorectal cancer cells

Nao Hondo, Masato Kitazawa, Makoto Koyama et al. · Cancer Letters · 2023 · 20 citations · Full text

Medicine, Colorectal Cancer, Pathology +7

Intraoperative visualization of morphological patterns of the thoracic duct by subcutaneous inguinal injection of indocyanine green in esophagectomy for esophageal cancer

Shigeo Tokumaru, Masato Kitazawa, Satoshi Nakamura et al. · Annals of Gastroenterological Surgery · 2022 · 16 citations · Full text

Drug sensitivity profile of minor KRAS mutations in colorectal cancer using mix culture assay: The effect of AMG‑510, a novel KRAS G12C selective inhibitor, on colon cancer cells is markedly enhanced by the combined inhibition of MEK and BCL‑XL

Masato Kitazawa, Yusuke Miyagawa, Makoto Koyama et al. · Molecular and Clinical Oncology · 2021 · 15 citations · Full text

Conditional Deletion of TAK1 in T Cells Reveals a Pivotal Role of TCRαβ+ Intraepithelial Lymphocytes in Preventing Lymphopenia-Associated Colitis

Hideki Sanjo, Shigeo Tokumaru, Shizuo Akira et al. · PLoS ONE · 2015 · 11 citations · Full text